Finance

Lists
Why is GMED down ၂.၇၀%?
Dive Deeper
GMED:NYSE
Globus Medical Inc
၇၆.၇၁ US$
-၂.၇၀%
(-၂.၁၃) 1D
၇၆.၇၁ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၇  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMED...
Open
၇၉.၃၅ US$
High
၇၉.၉၅ US$
Low
၇၆.၄၉ US$
Mkt. cap
ဋေ ၁.၀၃ ထ
Avg. vol.
၁.၅၈ သန်း
Volume
၁.၉၄ သန်း
P/E ratio
၁၉.၆၁
52-wk high
၁၀၁.၄၀ US$
52-wk low
၅၈.၅၁ US$
EPS
၃.၉၁ US$
Beta
၀.၉၆
Shares outstanding
၁၁.၂၆ ကုဋေ
No. of employees
၆ ထောင်
Open
၇၉.၃၅ US$
High
၇၉.၉၅ US$
Low
၇၆.၄၉ US$
Mkt. cap
ဋေ ၁.၀၃ ထ
Avg. vol.
၁.၅၈ သန်း
Volume
၁.၉၄ သန်း
P/E ratio
၁၉.၆၁
52-wk high
၁၀၁.၄၀ US$
52-wk low
၅၈.၅၁ US$
EPS
၃.၉၁ US$
Beta
၀.၉၆
Shares outstanding
၁၁.၂၆ ကုဋေ
No. of employees
၆ ထောင်
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Globus Medical (GMED) Unveils New Spine Platforms Following A Narrative Of Undervaluation
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Stifel keeps USD 76.43 target for Globus Medical stock
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
GMED or AXGN: Which Is the Better Value Stock Right Now?
Zacks
Zacks
·
ပြီးခဲ့သည့် ၁ ရက်
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc
CEOKeith Pfeil
Employees၆ ထောင်
Founded၂၀၀၃
Headquarters-
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to GMED in the past 3 months
Buy
Buy
9
Hold
4
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for GMED in the last 3 months.
Highest
Current ၇၆.၇၁ US$
၁၁၇.၀၀ US$ (+၅၂.၅၂%)
Average
၉၈.၇၅ US$ (+၂၈.၇၃%)
Lowest
၈၂.၀၀ US$ (+၆.၉၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Reiterated
၈၅.၀၀ US$
+၁၀.၈%
10/07/2026
Kendall Au
RBC Capital
Buy
Maintained
၈၅.၀၀ US$
+၁၀.၈%
10/01/2026
Shagun Singh Chadha
RBC Capital
Buy
Maintained
၈၅.၀၀ US$
+၁၀.၈%
10/01/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
09/18/2026
Vik Chopra
BMO Capital
Buy
Maintained
၉၄.၀၀ US$
+၂၂.၅%
08/27/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
၁၁၅.၀၀ US$
+၄၉.၉%
08/28/2026
Keith Hinton
Freedom Capital Markets
Hold
Maintained
၈၇.၀၀ US$
+၁၃.၄%
08/27/2026
Travis Steed
Bank of America Securities
Buy
Maintained
၁၀၆.၀၀ US$
+၃၈.၂%
08/19/2026
Richard Newitter
Truist Financial
Buy
Reiterated
၁၀၀.၀၀ US$
+၃၀.၄%
08/07/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
၁၀၀.၀၀ US$
+၃၀.၄%
08/07/2026
David Saxon
Needham
Buy
Reiterated
၁၁၇.၀၀ US$
+၅၂.၅%
08/07/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
၁၁၅.၀၀ US$
+၄၉.၉%
08/06/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
၉၉.၀၀ US$
+၂၉.၁%
08/07/2026
Mathew Blackman
TD Cowen
Buy
Maintained
၁၁၅.၀၀ US$
+၄၉.၉%
08/06/2026
Unknown Analyst
UBS
Hold
Initiated
၈၂.၀၀ US$
+၆.၉%
07/28/2026
Patrick Wood
UBS
Hold
Initiated
၈၂.၀၀ US$
+၆.၉%
07/28/2026
Unknown Analyst
BMO Capital
Buy
Initiated
၉၄.၀၀ US$
+၂၂.၅%
07/09/2026
Matt Miksic
Barclays
Buy
Maintained
၁၂၃.၀၀ US$
+၆၀.၃%
05/11/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
၁၁၅.၀၀ US$
+၄၉.၉%
05/08/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
၁.၃၄ US$ / ၁.၁၀ US$
+၂၁.၉၁%beat
Revenue / Est. (USD)
၇၈.၉၆ ကုဋေ / ၇၈.၃၀ ကုဋေ
+၀.၈၅%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၇၆.၉၀ ကုဋေ
၈၂.၆၄ ကုဋေ
၇၅.၉၉ ကုဋေ
၇၈.၉၆ ကုဋေ
Cost of goods sold
၂၄.၆၁ ကုဋေ
၂၅.၄၆ ကုဋေ
၂၃.၄၁ ကုဋေ
၂၄.၁၄ ကုဋေ
Cost of revenue
၂၄.၆၁ ကုဋေ
၂၅.၄၆ ကုဋေ
၂၃.၄၁ ကုဋေ
၂၄.၁၄ ကုဋေ
Research and development expenses
၃.၈၁ ကုဋေ
၃.၆၂ ကုဋေ
၃.၆၅ ကုဋေ
၃.၆၃ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၈.၄၂ ကုဋေ
၃၀.၄၈ ကုဋေ
၂၉.၇၈ ကုဋေ
၂၈.၆၈ ကုဋေ
Operating expense
၃၅.၂၁ ကုဋေ
၃၇.၀၃ ကုဋေ
၃၆.၃၈ ကုဋေ
၃၅.၂၇ ကုဋေ
Total operating expenses
၅၉.၈၂ ကုဋေ
၆၂.၄၉ ကုဋေ
၅၉.၇၉ ကုဋေ
၅၉.၄၁ ကုဋေ
Operating income
၁၇.၀၈ ကုဋေ
၂၀.၁၅ ကုဋေ
၁၆.၂၀ ကုဋေ
၁၉.၅၅ ကုဋေ
Other non operating income
၁.၅၄ သန်း
၈.၆၅ သိန်း
၂.၂၅ သန်း
၁.၁၇ သန်း
EBT including unusual items
၁၄.၄၀ ကုဋေ
၁၆.၉၂ ကုဋေ
၁၅.၇၁ ကုဋေ
၁၈.၉၈ ကုဋေ
EBT excluding unusual items
၁၇.၃၆ ကုဋေ
၁၉.၈၅ ကုဋေ
၁၆.၇၅ ကုဋေ
၂၀.၂၉ ကုဋေ
Income tax expense
၂.၅၀ ကုဋေ
၂.၈၆ ကုဋေ
၃.၂၈ ကုဋေ
၃.၈၂ ကုဋေ
Effective tax rate
၁၇.၃၈%
၁၆.၉၂%
၂၀.၈၆%
၂၀.၁၅%
Other operating expenses
-
-
-
-
Net income
၁၁.၉၀ ကုဋေ
၁၄.၀၆ ကုဋေ
၁၂.၄၃ ကုဋေ
၁၅.၁၆ ကုဋေ
Net profit margin
၁၅.၄၇%
၁၇.၀၁%
၁၆.၃၆%
၁၉.၂၀%
Earnings per share
၁.၁၈
၁.၂၈
၁.၁၂
၁.၃၄
Interest and investment income
၁.၄၆ သန်း
၃.၃၁ သန်း
၅.၄၃ သန်း
၇.၀၇ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၄၆ သန်း
၃.၃၁ သန်း
၅.၄၃ သန်း
၇.၀၇ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၂၄.၂၀ ကုဋေ
၂၇.၀၃ ကုဋေ
၂၃.၁၉ ကုဋေ
၂၆.၅၁ ကုဋေ
Gain or loss from assets sale
၂.၃၁ သန်း
၄.၀၉ သန်း
၂.၄၅ သန်း
၃.၁၁ သန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ